Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
6 pending office actions • 5 art units • 6 examiners • 0 of 6 (0%) have an AI response strategy ready • 4 patents granted in the last 365 days
Kabushiki Kaisha Yakult Honsha has 6 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 6 distinct examiners and 5 distinct art units. KERSHAW, KELLY P is the busiest examiner, with 1 pending action.
The examiner count exceeds the art-unit count, indicating that at least one technical unit contains more than one pending matter. Counsel should compare those matters for consistent scientific terminology and disclosure positions while preserving examiner-specific responses. The KERSHAW file is one distinct assignment, and the profile does not identify repeated work by that examiner.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 2 (33%) |
| §103 only | 1 (17%) |
| Multi-statute (no §101) | 3 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KERSHAW, KELLY P | 1 | 17.7% | +16.0% |
| ARIANI, KADE | 1 | 75.0% | +32.0% |
| OGUNBIYI, OLUWATOSIN A | 1 | 63.8% | +41.2% |
| CRUM, MARY ABOU NADER | 1 | 39.2% | +63.7% |
| KOROTCHKINA, LIOUBOV G | 1 | 29.0% | +64.1% |
| LACHICA, ERICSON M | 1 | 29.8% | +35.2% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18562604 | METHOD FOR DETECTING LIVE LACTIC ACID BACTERIA WITH CARBOHYDRATE METABOLISM ACTIVITY | CRUM, MARY ABOU NADER | 14d |
| 18253956 | METHOD FOR COLLECTING CELLS OF MICROORGANISM IN SPECIMEN | KOROTCHKINA, LIOUBOV G | 35d |
| 18849788 | FERMENTED FOOD AND PRODUCTION METHOD THEREOF | KERSHAW, KELLY P | — |
| 18706814 | METHOD FOR DETERMINING RISK OF ADVERSE EVENT | ARIANI, KADE | — |
| 18705636 | ENHANCER OF NUMBER OF TCR CLONES | OGUNBIYI, OLUWATOSIN A | — |
| 17775775 | METHOD FOR PRODUCING FERMENTED MILK CONTAINING OLIGOSACCHARIDES | LACHICA, ERICSON M | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18562604 | METHOD FOR DETECTING LIVE LACTIC ACID BACTERIA WITH CARBOHYDRATE METABOLISM ACTIVITY | CRUM, MARY ABOU NADER | 14d |
| 18253956 | METHOD FOR COLLECTING CELLS OF MICROORGANISM IN SPECIMEN | KOROTCHKINA, LIOUBOV G | 35d |
| 18849788 | FERMENTED FOOD AND PRODUCTION METHOD THEREOF | KERSHAW, KELLY P | — |
| 18706814 | METHOD FOR DETERMINING RISK OF ADVERSE EVENT | ARIANI, KADE | — |
| 18705636 | ENHANCER OF NUMBER OF TCR CLONES | OGUNBIYI, OLUWATOSIN A | — |
| 17775775 | METHOD FOR PRODUCING FERMENTED MILK CONTAINING OLIGOSACCHARIDES | LACHICA, ERICSON M | — |
| Art Unit | Apps |
|---|---|
| 1645 | 2 |
| 1791 | 1 |
| 1651 | 1 |
| 1653 | 1 |
| 1792 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18849788 | FERMENTED FOOD AND PRODUCTION METHOD THEREOF | KERSHAW, KELLY P | 1791 | §102§103§112 | Non-Final OA | — | Pending | Sep 23, 2024 |
| 18706814 | METHOD FOR DETERMINING RISK OF ADVERSE EVENT | ARIANI, KADE | 1651 | §101§102§103§112 | Non-Final OA | — | Pending | May 02, 2024 |
| 18705636 | ENHANCER OF NUMBER OF TCR CLONES | OGUNBIYI, OLUWATOSIN A | 1645 | §101§112Other | Non-Final OA | — | Pending | Apr 29, 2024 |
| 18562604 | METHOD FOR DETECTING LIVE LACTIC ACID BACTERIA WITH CARBOHYDRATE METABOLISM ACTIVITY | CRUM, MARY ABOU NADER | 1645 | §103§112 | Final Rejection | 14d | Pending | Nov 20, 2023 |
| 18253956 | METHOD FOR COLLECTING CELLS OF MICROORGANISM IN SPECIMEN | KOROTCHKINA, LIOUBOV G | 1653 | §103 | Non-Final OA | 35d | Pending | May 23, 2023 |
| 17775775 | METHOD FOR PRODUCING FERMENTED MILK CONTAINING OLIGOSACCHARIDES | LACHICA, ERICSON M | 1792 | §103§112 | Non-Final OA | — | Pending | May 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialKabushiki Kaisha Yakult Honsha has 6 pending office actions as of October 2026, spread across 5 art units and 6 examiners.
Kelly P Kershaw has the most, with 1 of Kabushiki Kaisha Yakult Honsha's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
